Valiant Laboratories Limited — Others, 12-11-2024: Appointment

Valiant Laboratories has announced a board meeting to approve several key updates: an increase in the authorized share capital from ₹45 crores to ₹60 crores, a new appointment of Mr. Ashok Lakhamshi Chheda as Non-Executive Independent Director for five years, and a resignation from Mr. Velji Karamshi Gogri as Independent Director due to health concerns. The company reported its financial results for the quarter and half-year ended September 30, 2024, showing total income of ₹21.7 crores and a net profit of ₹0.6 crores. The appointment of Mr. Chheda is expected to strengthen the board, while the resignation may raise concerns about governance continuity. Overall, these developments could provide a positive outlook for strategic growth moving forward.